Your browser doesn't support javascript.
loading
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy.
Gouard, S; Pallardy, A; Gaschet, J; Faivre-Chauvet, A; Bruchertseifer, F; Morgenstern, A; Maurel, C; Matous, E; Kraeber-Bodéré, F; Davodeau, F; Chérel, M.
Afiliação
  • Gouard S; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France.
  • Pallardy A; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France; CHU Nantes, Nuclear medicine department, Nantes, France.
  • Gaschet J; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France.
  • Faivre-Chauvet A; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France; CHU Nantes, Nuclear medicine department, Nantes, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
  • Bruchertseifer F; Institute for Transuranium Elements, Karlsruhe, Germany.
  • Morgenstern A; Institute for Transuranium Elements, Karlsruhe, Germany.
  • Maurel C; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France.
  • Matous E; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France.
  • Kraeber-Bodéré F; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France; CHU Nantes, Nuclear medicine department, Nantes, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
  • Davodeau F; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France.
  • Chérel M; INSERM UMR 892 - CRCNA, France; University of Nantes, France; CNRS UMR 6299, Nantes, France; Institut de Cancérologie de l'Ouest, Saint-Herblain, France. Electronic address: Michel.Cherel@univ-nantes.fr.
Nucl Med Biol ; 41 Suppl: e30-5, 2014 May.
Article em En | MEDLINE | ID: mdl-24759272

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioisótopos / Bismuto / Radioimunoterapia / Sindecana-1 / Quimiorradioterapia / Melfalan / Mieloma Múltiplo Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioisótopos / Bismuto / Radioimunoterapia / Sindecana-1 / Quimiorradioterapia / Melfalan / Mieloma Múltiplo Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article